Acuvax to move to Adelaide; Opko licenses universal flu vax tech;

Vaccine Market

Australia's Acuvax is moving its headquarters to Adelaide and plans to expand with about 20 new hires. Report

Vaccine Research

Miami-based Opko Health has licensed a new universal flu vaccine technology developed by Taiwanese scientists. Report

The first African made HIV vaccine started human trials in South Africa. "If we don't find a prevention strategy for South Africa we are in big trouble. We are not going to treat ourselves out of this epidemic," researcher Linda-Gail Bekker told the AFP. "We can't afford to let six million people die." Report

Researchers at the Johns Hopkins Malaria Research Institute have for the first time produced a malarial protein (Pfs48/45) in the proper conformation and quantity to generate a significant immune response in mice and non-human . primates for use in a potential transmission-blocking vaccine. Release

Novavax announced the selection of a Respiratory Syncytial Virus vaccine candidate that will be advanced into new preclinical studies to support an Investigational New Drug application. Release

Suggested Articles

GSK expects Shingrix supplies to rise slightly in 2020, but the real "step change" will come in 2024 with a brand-new manufacturing facility.

Ebola has claimed thousands of lives in recent outbreaks, but now the world has a licensed vaccine option in Merck's Ervebo.

Cosette Pharmaceuticals which was formed in December with a deal for dermatology projects has gone back to G&W Labs for a liquids plant.